A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal

Typhoid remains one of the major serious health concerns for children in developing countries. With extremely drug-resistant cases emerging, preventative measures like sanitation and vaccination, including typhoid conjugate vaccines (TCV) remain the mainstay in its prevention and control. Different...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Shipra, Shah, Gauri Shankar, Bhatta, Nisha Keshary, Poudel, Prakash, Rai, Basant, Uranw, Surendra, Tripathi, Prashant Mani, Khanal, Basudha, Ghimire, Anup, Rai, Nikita, Gupta, Birendra Prasad, Vemula, Sridhar, Wartel, T. Anh, Sahastrabuddhe, Sushant, Saluja, Tarun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Novel Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142305/
https://www.ncbi.nlm.nih.gov/pubmed/37128723
http://dx.doi.org/10.1080/21645515.2023.2203634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142305/
https://www.ncbi.nlm.nih.gov/pubmed/37128723
http://dx.doi.org/10.1080/21645515.2023.2203634

Ejemplares similares